KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Cash & Equivalents (2016 - 2025)

Alto Ingredients (ALTO) has 15 years of Cash & Equivalents data on record, last reported at $32.5 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 3.2% year-over-year to $32.5 million; the TTM value through Sep 2025 reached $32.5 million, down 3.2%, while the annual FY2024 figure was $35.5 million, 18.17% up from the prior year.
  • Cash & Equivalents reached $32.5 million in Q3 2025 per ALTO's latest filing, up from $29.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $79.4 million in Q1 2021 and bottomed at $21.2 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $38.0 million, with a median of $32.5 million recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: soared 196.53% in 2021, then tumbled 64.7% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $50.6 million in 2021, then dropped by 27.97% to $36.5 million in 2022, then fell by 17.67% to $30.0 million in 2023, then rose by 18.17% to $35.5 million in 2024, then dropped by 8.33% to $32.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $32.5 million in Q3 2025, $29.8 million in Q2 2025, and $26.8 million in Q1 2025.